Unlocking Cancer's Hidden Targets: The Revolutionary Science of Cancer-Testis Antigens in Modern Immunotherapy is a comprehensive scientific guide that explores the groundbreaking intersection of cancer-testis antigen research and modern immunotherapy. Written by Dr. Maurizio Chiriva Internati, a pioneering researcher with over two decades of experience in immuno-oncology, this book provides an in-depth examination of how cancer-testis antigens are transforming the landscape of personalized cancer treatment. From the foundational discovery of sperm protein 17 as a novel cancer-testis antigen to the development of AI-driven platforms for personalized target discovery, this work covers the full spectrum of translational research in cancer immunotherapy. Readers will explore the molecular mechanisms underlying cancer-testis antigen expression, the clinical applications of cancer vaccines across multiple tumor types, and the revolutionary manufacturing processes that are making personalized immunotherapy a clinical reality. This book bridges the gap between laboratory science and clinical application, offering oncologists, immunologists, biotech professionals, medical students, and researchers a thorough understanding of the current state and future directions of cancer-testis antigen-based immunotherapy. With over 215 scientific references and detailed analysis of FDA regulatory pathways, vaccine development strategies, and emerging technologies including mRNA-based cancer vaccines, this work serves as both an authoritative reference and an accessible guide to one of the most promising frontiers in modern oncology.